Studies of T-cell regeneration using animal models have consistently s
hown the importance of the thymus for T-cell regeneration. In humans,
recent studies have shown that declines in thymic T-cell regenerative
capacity begins relatively early in life, resulting in a limited capac
ity for T-cell regeneration by young adulthood. As a result, adult hum
ans who experience profound T-cell depletion regenerate T cells primar
ily via relatively inefficient thymic-independent pathways, resulting
in prolonged CD4 depletion, CD4(+) and CD8(+) subset alterations, limi
ted TCR repertoire diversity and a propensity for activation induced c
ell death. These limitations in T-cell regeneration have significant c
linical implications in the setting of HIV infection and bone marrow t
ransplantation and may also contribute to immunologic abnormalities as
sociated with normal aging. While the mechanisms responsible for thymi
c aging are not well understood, current evidence suggests that change
s within the thymus itself are primary, while age-related changes in m
arrow T-cell progenitors and inhibitory factors within the extrathymic
host milieu contribute to a lesser extent. The development of therapi
es which can reverse thymic aging are critical for improving outcome i
n clinical settings of T-cell depletion, and could potentially improve
immunologic function in normal aged hosts.